Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Schwartz Insider Profile
4 Followers
Brian Schwartz, Director at Mereo BioPharma, holds 100.00K shares in Mereo BioPharma (Ticker: GB:MPH), holds 100.00K shares in Mereo Biopharma Group Plc (Ticker: MREO). Most recently, Brian Schwartz ― shares of Mereo BioPharma on ― for an estimated value of ―.
Brian Schwartz Mereo BioPharma (MPH)Director
Mereo BioPharma (MPH)
Director
Not Ranked
Brian Schwartz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Brian Schwartz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brian Schwartz
Brian Schwartz's Trading History
Mereo BioPharma
―
―
―
£26.50K
Mereo Biopharma Group Plc
Oct 09, 2020
Director
Informative Buy
47.00K
$359.00K
List of latest transactions for each holding click on a transaction to see Brian Schwartz's performance on stock
You May Also Like
Brian Schwartz insider profile FAQ
What is the percentage of profitable transactions made by Brian Schwartz?
The percentage of profitable transactions made by Brian Schwartz is ―.
What is the average return per transaction made by Brian Schwartz?
The average return per transaction made by Brian Schwartz is ―.
What stocks does Brian Schwartz hold?
Brian Schwartz holds: GB:MPH, MREO stocks.
What was Brian Schwartz’s latest transaction?
Brian Schwartz latest transaction was an Uninformative Buy of ―.
What was Brian Schwartz's most profitable transaction?
Brian Schwartz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brian Schwartz's role in Mereo BioPharma?
Brian Schwartz's role in Mereo BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.